[{"address1": "18706 North Creek Parkway", "address2": "Suite 104", "city": "Bothell", "state": "WA", "zip": "98011", "country": "United States", "phone": "425 620 8501", "website": "https://www.athira.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Athira Pharma, Inc., clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. Its product pipeline includes ATH-1105 for the treatment of amyotrophic lateral sclerosis, which is in phase 1 clinical trial; ATH-1020 for the treatment of neurodegenerative diseases, which is phase 1 clinical trial, as well as early compounds which is in preclinical phase. The company was formerly known as M3 Biotechnology, Inc. and changed its name to Athira Pharma, Inc. in April 2019. Athira Pharma, Inc. was incorporated in 2011 and is headquartered in Bothell, Washington.", "fullTimeEmployees": 26, "companyOfficers": [{"maxAge": 1, "name": "Dr. Mark J. Litton M.B.A., Ph.D.", "age": 57, "title": "President, CEO & Director", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 1045398, "exercisedValue": 0, "unexercisedValue": 16976}, {"maxAge": 1, "name": "Dr. Kevin  Church Ph.D.", "age": 40, "title": "Chief Scientific Officer", "yearBorn": 1985, "fiscalYear": 2024, "totalPay": 680085, "exercisedValue": 0, "unexercisedValue": 5012}, {"maxAge": 1, "name": "Mr. Mark F. Worthington J.D.", "age": 59, "title": "General Counsel, Chief Compliance Officer & Corporate Secretary", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 681523, "exercisedValue": 0, "unexercisedValue": 5012}, {"maxAge": 1, "name": "Mr. Robert  Renninger", "age": 41, "title": "Chief Financial Officer", "yearBorn": 1984, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Julie  Rathbun", "title": "Head of Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Javier  San Martin M.D.", "age": 60, "title": "Chief Medical Officer", "yearBorn": 1965, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 10, "boardRisk": 6, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1768176000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 7.19, "open": 7.3, "dayLow": 6.63, "dayHigh": 7.3499, "regularMarketPreviousClose": 7.19, "regularMarketOpen": 7.3, "regularMarketDayLow": 6.63, "regularMarketDayHigh": 7.3499, "payoutRatio": 0.0, "beta": 2.802, "forwardPE": -4.141104, "volume": 70313, "regularMarketVolume": 70313, "averageVolume": 1073487, "averageVolume10days": 57497, "averageDailyVolume10Day": 57497, "bid": 2.94, "ask": 5.06, "bidSize": 200, "askSize": 200, "marketCap": 26621540, "fiftyTwoWeekLow": 2.1955, "fiftyTwoWeekHigh": 8.36, "allTimeHigh": 347.9, "allTimeLow": 2.1955, "fiftyDayAverage": 5.6325, "twoHundredDayAverage": 4.120535, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1518459, "profitMargins": 0.0, "floatShares": 981200, "sharesOutstanding": 3943887, "sharesShort": 7025, "sharesShortPriorMonth": 71309, "sharesShortPreviousMonthDate": 1763078400, "dateShortInterest": 1765756800, "sharesPercentSharesOut": 0.0018000001, "heldPercentInsiders": 0.13366, "heldPercentInstitutions": 0.85516, "shortRatio": 0.37, "shortPercentOfFloat": 0.0021, "impliedSharesOutstanding": 3943932, "bookValue": 6.792, "priceToBook": 0.99381626, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -37723000, "trailingEps": -9.67, "forwardEps": -1.63, "lastSplitFactor": "1:10", "lastSplitDate": 1758153600, "enterpriseToEbitda": -0.04, "52WeekChange": 0.11196172, "SandP52WeekChange": 0.14684999, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "ATHA", "underlyingSymbol": "ATHA", "shortName": "Athira Pharma, Inc.", "longName": "LeonaBio, Inc.", "firstTradeDateEpochUtc": 1600435800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "bcfbfaea-5231-3987-ba3c-d263d037ec62", "messageBoardId": "finmb_266015004", "gmtOffSetMilliseconds": -18000000, "currentPrice": 6.75, "targetHighPrice": 4.0, "targetLowPrice": 4.0, "targetMeanPrice": 4.0, "targetMedianPrice": 4.0, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 25226000, "totalCashPerShare": 6.396, "ebitda": -38295000, "totalDebt": 912000, "quickRatio": 9.051, "currentRatio": 9.697, "debtToEquity": 3.405, "returnOnAssets": -0.42212, "returnOnEquity": -0.89424, "freeCashflow": -30363876, "operatingCashflow": -52345000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2026-02-21"}]